As the climate changes, how can we protect our food systems and our health?
Overloaded sex, gender & health equity conversations: What is working? What is worth considering?
Bitesize: What if we could switch the salt to reduce blood pressure?
George Institute research team wins MRFF funding to help transform primary care
Bite size: What can we do differently? Learning to live again after stroke - insights for research and individuals
Bite size: What is the most serious type of stroke? Investigating new treatments– I-CATCHER trial
Why do we need a policy to address gender data gaps in health and medical research?
Professor Anushka Patel
Professor Anushka Patel is CEO and Director of The George Institute for Global Health and Scientia Professor at UNSW, Sydney. She is a cardiologist with research interests in the prevention and management of common chronic conditions through large-scale clinical trials and implementation science.
Anushka undertook her medical training at the University of Queensland, with subsequent postgraduate research degrees from Harvard University and University of Sydney. Anushka is a Fellow of the Royal Australasian College of Physicians and of the Australian Academy of Health and Medical Sciences and is a Director and Trustee of the Pulmonary Vascular Research Institute.
Prof Bala Venkatesh
Bala Venkatesh is Director of Intensive care at the Wesley Hospital, Pre-Eminent specialist in Intensive Care Medicine at the Princess Alexandra Hospital, Brisbane, Professor of Intensive Care Medicine at the University of Queensland, and at the University of New South Wales, and Professorial Fellow at the George Institute for Global Health, Sydney Australia. He is the Chairman of the Queensland Health Statewide Sepsis Steering Committee. He is a Fellow of the Australian Academy of Health and Medical Sciences.
He has completed Fellowship training in Internal Medicine, Anaesthesia and Intensive Care Medicine. He then undertook a research degree from the University of Birmingham, UK which led to the award of an MD. He pioneered the development of a continuous blood gas monitoring system which reached clinical application.
He served as the President for the College of Intensive Care Medicine of Australia and New Zealand between 2014–2016. He led the international taskforce on gender equity in Intensive Care which influenced guidelines in the World Federation of Intensive Care. As President of the College of Intensive Care, he led the task force on bullying and discrimination which have informed College policy.
He led the NHMRC funded multi-center international ADRENAL trial which is the largest septic shock trial to date. This was published in the New England Journal of Medicine and ranked in the top 12 articles of 2018. He has served on several Data Safety Monitoring Committees and on the Management committee of RCTs in sepsis. His research interests include glucocorticoid physiology in critical illness including the development of the idea of the "sick euadrenal state," sepsis and vitamin D in critical illness.
In 2020, following the Covid-19 pandemic, he contributed to the REMAP-CAP steroid trial design and development and was on its writing committee recently reported in JAMA, which influenced guideline development. He was instrumental in the development of the George Institute's Covid-19 research program in India and played a key role in the set up of the COVID Steroid 2 trial in India which was also published in JAMA. He is currently investigating the role of fludrocortisone in septic shock.
He has published more than 250 papers, 40 book chapters, and edited 2 books. He has supervised 8 PhD students. He is now a Level 3 NHMRC Investigator Fellow.
Professor Bruce Neal
Professor Neal is a UK-trained physician who has 25 years’ experience in clinical, epidemiological, and public health research with a focus on heart disease, stroke and diabetes.
He has a longstanding interest in high blood pressure and diabetes and the potential for both clinical interventions and changes in the food supply to deliver health gains. His work has been characterised by its focus on collaboration, quantitation, translation and impact.
He holds professorial appointments at UNSW Sydney, Imperial College London, and an honorary appointment at the University of Sydney. He has published some 450 scientific papers and since 2016 has been identified by Thomson Reuters as one of ‘The World’s Most Influential Scientific Minds’ - an acknowledgement bestowed on just a few thousand researchers across all disciplines worldwide.
He has deep expertise in the conduct of large-scale clinical trials addressing cardiovascular disease but has also done a significant body of work addressing food policy issues related to sugars, fats, portion size and food labelling.
Frances Bass
Frances Bass works part-time at The George Institute for Global Health as Program Manager in the Critical Care Program. She also works at Royal North Shore Hospital as an Intensive Care Clinical Research Manager.
Frances is a Registered Nurse having completed a Bachelor of Nursing, Graduate Certificate in Critical Care, and Masters of Science (Research). She has extensive experience in the management of critical care clinical trials operations including investigator-initiated, collaborative group and commercially sponsored trials.
Frances sits on a number of scientific management committees. She is Secretary for the Australian College of Critical Care Nurses (ACCCN) NSW/ACT Branch Management Committee and a member on the ACCCN Research Advisory Committee. She is Deputy Chair of the Northern Sydney Local Health District, Human Research Ethics Committee.